Christoph Boehringer (#607)
- $ 7 B
- Pharmaceuticals
- Germany
- M
- 55 Years
'A form of double taxation': Are management fees on new houses quietly getting out of control?
Trump Official Blames Biden Admin for Economic ‘Mess’ — As Resurfaced Clip Shows Him Saying Trump Would Own the Economy By 2026
Is Precigen, Inc. (PGEN) A Good Stock To Buy Now?
Is Transocean Ltd. (RIG) A Good Stock To Buy Now?
Tesla is selling Chinese-made cars in Canada to escape the tariffs that both China and America imposed on it
Insecurity didn’t start with Tinubu, group defends president’s security record
Vibrating pillow sleeve warns deaf sleepers of burglars and fires
How Kepler built verifiable AI for financial services with Claude
Is ASML Holding N.V. (ASML) A Good Stock To Buy Now?
5-Letter Words Ending in ‘Y’ to Help You Improve Your Wordle Skills
About Me
Christoph Boehringer's fortune stems from Boehringer Ingelheim, the world's largest private pharmaceutical company. Boehringer Ingelheim traces its roots to 1885, when Albert Boehringer started a small factory with 28 employees, making ingredients for pharmacies, textile merchants and the food industry. By the time of the founder's death the company had a workforce of 1,500. Today Boehringer Ingelheim employs 53,000 people and has a presence in 130 markets. Some of its best-selling drugs include those that treat COPD, anti-coagulation and type 2 diabetes. Christian along with 14 members of the family own equal parts of the company; all of them are part of the third, fourth or fifth generation.
Achievements
Career Highlights
A snapshot of the defining milestones, leadership decisions, and breakthroughs that shaped Christoph Boehringer’s rise and global influence.
Wealth Growth
Net Worth Growth Over Time
Tracking Christoph Boehringer’s net worth journey over the years, highlighting key growth phases and financial milestones.
Current Net Worth: $6.6B
(May 4, 2026)
© Iconic Billionaires